Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Guillaume, Escure"'
Autor:
Guillaume Escure, Elise Fournier, Cynthia Saade, Lama Hasan Bou Issa, Inès Arib, Rémi Tilmont, Nicolas Gazeau, Binta M. Thiam, Morgane Chovet, Maxime Delforge, Nicolas Gower, Léa Fléchon, Doriane Cavalieri, Paul Chauvet, Morgane Nudel, Laure Goursaud, Céline Berthon, Bruno Quesnel, Thierry Facon, Claude Preudhomme, Nicolas Duployez, Salomon Manier
Publikováno v:
Haematologica, Vol 109, Iss 4 (2023)
Externí odkaz:
https://doaj.org/article/a2a5f90de1ed463a8a881841c3ce5223
Publikováno v:
La Presse Médicale Formation. 3:492-498
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51e2dd6b7c7c92d74ebde97069ff6e9d
https://doi.org/10.1016/j.lpmfor.2022.10.013
https://doi.org/10.1016/j.lpmfor.2022.10.013
Autor:
Guillaume, Escure1, Manier, Salomon1,2 salomon.manier@chru-lille.fr
Publikováno v:
Hematologie. 2021 Supplement 3, Vol. 27, p26-34. 9p.
Autor:
Katarina K. Jovanović, Guillaume Escure, Jordane Demonchy, Alexandre Willaume, Zoe Van de Wyngaert, Meryem Farhat, Paul Chauvet, Thierry Facon, Bruno Quesnel, Salomon Manier
Publikováno v:
Frontiers in Oncology, Vol 8 (2019)
Multiple Myeloma (MM) is an incurable disease characterized by a clonal evolution across the course of the diseases and multiple lines of treatment. Among genomic drivers of the disease, alterations of the tumor suppressor TP53 are associated with po
Externí odkaz:
https://doaj.org/article/eaa463525d8343609bb2b011e5016b0f
Autor:
Guillaume Escure, Salomon Manier
Publikováno v:
Bulletin du Cancer. 108:S205-S212
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::468108ec60bbeedc05ee657f1ed6c6ba
https://doi.org/10.1016/j.bulcan.2021.10.003
https://doi.org/10.1016/j.bulcan.2021.10.003
Autor:
Nathalie Cambier, Guillaume Chanteau, Guillaume Escure, Remi Tilmont, Mathieu Wemeau, Jean Baptiste Bossard, Loïc Renaud, Julia Hieulle, Sarah Barbieux, Franck Morschhauser, Eileen M Boyle, Louis Terriou, Benjamin Carpentier
Publikováno v:
European Journal of Haematology
European Journal of Haematology, 2021, European Journal of Haematology, 107 (3), pp.370-373. ⟨10.1111/ejh.13667⟩
European Journal of Haematology, 2021, European Journal of Haematology, 107 (3), pp.370-373. ⟨10.1111/ejh.13667⟩
Despite recent therapeutic advances the outcome of elderly or frail patients with Recurrent/Refractory (R/R) Primary (PCNSL) and Secondary CNS Lymphoma (SCNSL) is particularly dire. We retrospectively analyzed 22 immunocompetent adults with R/R PCNSL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9d166e686a3224d8311fa264b8bed6c
https://doi.org/10.1111/ejh.13667
https://doi.org/10.1111/ejh.13667
Autor:
Guillaume, Escure, Morgane, Nudel, Louis, Terriou, Meryem-Maud, Farhat, David, Launay, Delphine, Staumont-Salle, Eric, Hachulla, Sophie, Gautier, Sébastien, Sanges
Publikováno v:
European journal of dermatology : EJD. 32(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a18bb83a0d0379f769a5f1904aa60bfb
https://pubmed.ncbi.nlm.nih.gov/35514102
https://pubmed.ncbi.nlm.nih.gov/35514102
Autor:
Marie-Pierre Noel, Emilie Fréalle, Eileen M Boyle, Faith E. Davies, Charles Herbaux, Guillaume Escure, Hélène Demarquette, Alexandre Willaume, Thierry Facon, Jessica Caro, Gareth J. Morgan, Camille Cordier, Zoé Van de Wyngaert, Jordane Demonchy, Claire Bories, Karine Faure, Serge Alfandari
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:e545-e547
In Western countries, Cryptosporidium parvum infection is considered a rare opportunistic parasitic disease, most commonly seen in immunocompromised patients. Although most cases have been described in Acquired ImmunoDeficiency Syndrome (AIDS) patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acb796d857cb2724ff402b4cd80ed1a0
https://doi.org/10.1016/j.clml.2021.01.019
https://doi.org/10.1016/j.clml.2021.01.019
Autor:
Guillaume, Escure, Salomon, Manier
Publikováno v:
Bulletin du cancer. 108(10S)
Immunotherapies have recently emerged as potential game changers in the treatment of multiple myeloma (MM). Those include monoclonal antibodies (targeting CD38 or CS1), bispecific antibodies (BsAb, mainly targeting BCMA, GPRC5D or FcRH5), antibody-dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ec234e49a1eaa9164f4a257a8ef5bcc4
https://pubmed.ncbi.nlm.nih.gov/34920804
https://pubmed.ncbi.nlm.nih.gov/34920804
Autor:
Salomon Manier, Tiziano Ingegnere, Guillaume Escure, Chloé Prodhomme, Morgane Nudel, Suman Mitra, Thierry Facon
Publikováno v:
Blood Reviews. 54:100929
Chimeric antigen receptor T cells (CAR-T cells) have emerged as a potentially transformative new approach to treating hematological malignancies. Ide-cel, an autologous B cell maturation antigen (BCMA) targeting CAR-T cells, has recently been approve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac38bab56c683a122d942b47210c8312
https://doi.org/10.1016/j.blre.2022.100929
https://doi.org/10.1016/j.blre.2022.100929